Investment in cancer research directly impacts the development of new cancer treatments. Increased funding leads to breakthroughs in targeted therapies, immunotherapies, and combination treatments that offer higher efficacy and fewer side effects compared to traditional chemotherapy and radiation. Furthermore, it facilitates the translation of laboratory discoveries into clinical applications.
